Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM

By Chris Wack

Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System.

The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes.

This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes.

Through its affiliated companies, Anthem, now Elevance Health Inc., serves people across 14 states, including more than 45 million within its family of health plans.

The stock hit its 52-week low of 77 cents on May 12.

Write to Chris Wack at [e-mail]

(END) Dow Jones Newswires

08-03-22 1045ET